BOM — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Xyallxyall.comFeb 2026
Xyall builds an automated tissue dissection platform, the Tissector, that combines precision robotics, digital pathology, and workflow software to select and prepare tissue samples for molecular pathology testing.
HealthtechMedical DevicesRobotics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.